The invention generally relates to methods for degrading nucleic acid.
Bioanalytical techniques commonly require reagents, buffers, and equipment that is free of contaminating DNA. Contaminating DNA can interfere with high-sensitivity methods, such as hybrid assay, and can imperil any process that relies upon DNA amplification prior to subsequent analysis, e.g., sequencing. Contaminating DNA can originate from a researcher directly or it can be introduced by way of contaminated surfaces, reagents, buffers, or air. Accordingly, detailed protocols are available for creating “DNA-free workspaces” and for clearing buffers, etc. from contaminating DNA.
A common protocol for providing a “DNA-free workspace” relies on regular bleach washing of all laboratory surfaces and equipment, the use of absorbent bench pads on all surfaces, and the use of dedicated hood space for certain key procedures (e.g., PCR). Other protocols recommend regularly exposing surfaces to UV light in order to degrade or inactivate contaminating DNA. Maintaining a “DNA-free workspace” also involves judicious use of disposable labware, such as pipette tips and sample vials.
In addition to keeping a clean workspace, analytical reagents, washes, and buffers must be free of contaminant DNA. In many cases, this involves procuring “DNA-free” reagents or buffers from manufacturers who prepare the reagents and buffers under strict conditions and perform post-production analysis to assure that no DNA is present. For example DNA-free buffers are available from MoBio (Carlsbad, Calif.). The cost of using certified DNA-free reagents can be substantial, however. For example, 500 ml of DNA-free PBS buffer may cost approximately $50 with shipping.
In other situations, DNA contamination may be removed from reagents, buffers, and samples using DNase and DNase clean-up kits. DNases are endonucleases that catalyze hydrolytic cleavage of phosphodiester linkages in the DNA backbone. A variety of DNases are known, and they may cleave DNA in different places (e.g., ends, mid-chain, specific sequences), or cleave single-stranded DNA over double-stranded DNA, or vice versa. A DNase treatment of a reagent will typically involve introduction of prepared DNase, such as AMBION DNase I (Life Technologies, Carlsbad, Calif.) along with a buffered solution containing substrates and optimized ionic species. In some protocols, it may be necessary to use high-turnover, recombinant DNase, such as TURBO DNase, also available from Life Technologies. After a reagent or sample is treated with DNase, the DNase may be degraded with heat, alcohol, or EDTA in order to prevent interference by the DNase in subsequent processing.
While good laboratory practices and judicious use of DNase can prevent much DNA contamination, some instances of DNA contamination are harder to control. For example, precision instrument components, such as ports, injectors, and columns are not typically disposable because of the high manufacturing costs. Additionally, it may not be possible to easily decontaminate the components using standard techniques (e.g., bleach cleaning) because the cleaning compounds may damage the components. In other situations where direct decontamination is not possible, it may also not be feasible to use DNase to digest contaminant DNA because of concerns over cross-contamination or an inability to deactivate the DNase afterward with heat or alcohol. DNase degradation products may also become a source of contamination in proteomic measurements.
Additionally, reliance on certified DNA-free reagents and disposable labware is expensive and produces a large amount of solid waste.
The invention generally provides methods for degrading nucleic acid. Methods of the invention are useful for decontaminating labware, reagents, buffers, and samples. Aspects of the invention are accomplished using reactive oxygen species to degrade nucleic acid. An advantage of the reactive oxygen species is their efficiency of degrading nucleic acid and the ease by which the decontaminating solution can be cleared so that sample nucleic acid is not affected by the decontaminating solution.
The reactive oxygen species can be easily produced using reactions between metal ions (Fe2+, Fe3+) and hydrogen peroxide (H2O2). The reactive oxygen species may include peroxides (O22−), superoxides (O2−), and hydroxyl radicals (OH.), however the exact mixture of the reactive oxygen species may change with time and pH. Using metal ion and peroxide solutions, a buffer or reagent can be quickly and efficiently cleared of nucleic acid. After nucleic acid clearance, the buffer may be heated to dissociate remaining H2O2 or exposed to an ion exchange resin or chelating agent to remove or sequester the metal ions. The method is also useful for decontaminating laboratory equipment, separation media, and supports for separation media, such as magnetic beads.
In one instance, the invention is a method for degrading contaminant DNA associated with a separation medium or support. The method includes contacting the separation medium or support with a solution comprising metal ions and peroxide ions. The metal ions are selected from iron, manganese, copper, nickel, and cobalt, however they are typically iron, such as Fe2+ ions or Fe3+ ions. Typically, the separation medium or support is allowed to contact the solution comprising metal ions and peroxide ions for some time and then the decontamination solution is deactivated. The solution can be deactivated by raising the temperature of the solution to dissociate hydrogen peroxide or the solution can be deactivated by binding the metal ions with an ion-exchange medium or a chelating agent. In a specific embodiment, the separation medium or support is decontaminated with a solution comprising hydrogen peroxide and Fe2(SO4)3.
In another instance, the invention is a method for clearing contaminant DNA from a buffer solution, analytical reagent, or sample. The method includes adding metal ions and peroxide ions to the buffer solution, analytical reagent, or sample and later heating the buffer solution, analytical reagent, or sample to dissociate the peroxide ions. In another embodiment, the method includes adding metal ions and peroxide ions to the buffer solution, analytical reagent, or sample and later binding the metal ions.
Using the methods described herein, it is possible to inexpensively and effectively remove contaminant DNA from labware, reagents, buffers, samples, laboratory equipment, separation media, and supports. Use of the methods of the invention will reduce measurement, amplification, and sequencing errors resulting from contaminant DNA.
The invention provides alternative methods for removing contaminant DNA from reagents, labware, and laboratory equipment. Unwanted DNA is a common source of error in bioanalytical analysis, and constant vigilance is needed when using techniques, such as PCR, where minute amounts of DNA can compromise measurements. As discussed above, while DNase may be used to decontaminate some buffers and samples, there are instances where DNase clean-up is not feasible. Additionally, bleach decontamination may not be feasible because of inaccessibility to key instrument components or reactivity with the cleaning products.
The invention uses reactive oxygen species, and reactions that produce reactive oxygen species, to oxidize and degrade DNA present in reagents, buffers, samples, and on laboratory equipment. The methods disclosed involve combining reactive oxygen species, such as hydrogen peroxide, with metal ions, such as Fe2+. The reagents are inexpensive, easy to combine, and the remnants of the reaction are easily removed from the reagents, buffers, etc. after degradation of DNA.
Oxidative species are recognized as a source of genetic mutation. The reactive oxygen species implicated in metal-ion degradation of DNA include peroxides (O22−), superoxides (O2−), singlet oxygen (O2*), and hydroxyl radicals (OH.). The complete mechanism for the formation of the reactive oxygen species in the presence of metal ions has not been elucidated. However, it is time and pH-dependent, and likely includes some or all of the following reactions (M=metal ion, e.g., Fe):
O2+e−→O2− (1)
2H2O2→2H2O+O2 (2)
2O2−+2H+→O2+H2O2 (3)
O2−+M3+→M2++O2 (4)
M2++H+H2O2→M3++OH.+H2O (5)
M2++H2O2→M3++OH.+OH− (6)
M2++H2O2→MO2++H2O (7)
MO2++H+→MOH3+→M3++OH. (8)
M3++H2O2→MOOH2++H+→M2++2H++O2− (9)
M3++H2O2→M2++H++OOH− (10)
See Henle and Linn, “Formation, Prevention, and Repair of DNA Damage by Iron/Hydrogen Peroxide,” J. Bio. Chem., vol. 272, 19095-19098 (1997), incorporated by reference herein in its entirety.
A number of different metal ions may react with activated oxygen species through combinations of reactions 1-10 above. The metals ions include iron, manganese, copper, nickel, cobalt, or zinc. The oxidation state of the ions may be +1, +2, +3, +4, or +5, however, +2 and +3 ions are most involved in the creation of reactive oxygen species. Other oxidation states, e.g., +1, +4, +5, are achieved through oxidation or reduction with other species. Because a variety of metal ions may participate in the degradation pathway, DNA protocols often call for the sequestering of metal ions, e.g., with EDTA, to avoid these degradation processes.
Research suggests that DNA degradation in the presence of reactive oxygen species is primarily driven by abstraction of hydrogen atoms from the sugar phosphate backbone. In particular, the hydrogen atom attached to the C5′ carbon of the deoxyribose sugar is most available in double-stranded DNA, and most likely to react with a reactive oxygen species. Accordingly, cleavage of the bond between the C5′ and C6′ atoms is most often observed.
Nonetheless, upon removal of a hydrogen atom, a deoxyribose carbocation may undergo one or more rearrangements prior to cleavage. Upon rearrangement, the molecule may cleave at another point in the deoxyribose molecule, i.e., not between the C5′ and C6′ atoms. Furthermore, the stability of the carbocation (or rearrangement product) influences the equilibrium between reactants (DNA+oxidative species) and products (broken chain+water). In particular, the lack of stable carbocation products for ribose sugars explains why RNA is much less susceptible to oxidative degradation than DNA. See Gates, “The Chemical Reactions of DNA Damage and Degradation,” Reviews of Reactive Intermediate Chemistry, Platz et al., eds., p. 351-356 (2007), incorporated herein by reference.
In addition to abstracting hydrogen from the deoxyribose sugar, oxidative species may also damage DNA bases. In particular, the N7 to C8 bond in the purine moiety (adenine and guanine) and the C5 to C6 bond in the pyrimidine moiety (cytosine and thymine) are susceptible cleavage by oxidative species. Because these cleavages do not break the sugar phosphate chain, the cleavages may not lead to degradation of the DNA chain, and the bases may be repaired in subsequent processing steps. Among bases, cytosine is most likely damaged by oxidative species, followed by thymine, followed by adenine, followed by guanine. See Henle et al., “Oxidative Damage to DNA Constituents by Iron-mediated Fenton Reactions,” J. Bio. Chem., vol. 271, p. 21177-86 (1996), incorporated herein by reference. Other mechanisms, including radical-metal attachment chemistry, have also been implicated in DNA degradation. See Henle and Lin.
Methods of the invention include addition of metal ions and oxidative species to reagents, buffers, and samples. In most instances, metal ions of the desired oxidation state are readily available as salts, for example FeCl3, Fe2(SO4)3, Fe(SO4), and (NH4)2Fe(SO4)6. High purity metal salts are available from chemical suppliers such as Sigma-Aldrich (St. Louis, Mo.). In some instances, the metal salts are water soluble. In other instances, the aqueous solubility of the metal salts is increased with the addition of acid, for example hydrochloric acid or sulfuric acids, or with the addition of alcohols. Metal salts that may be used with methods of the invention include copper salts such as Cu2S, CuS, Cu(CH3COO)2, and Cu(SO4); manganese salts such as Mn(CO3) and Mn(SO4); nickel salts such as NiCl6, (NiCl4)SO4, and Ni(SO4); and cobalt salts such as Co(SO4). In some embodiments, a final concentration of metal ions is 1 μM or greater, e.g., 10 μM or greater, e.g., 100 μM or greater, e.g., 1 mM or greater, e.g., 10 mM or greater, e.g., 100 mM or greater. Because the metal ions are not consumed during the degradation, the concentration of the metal ions before and after degradation should be approximately equivalent.
The oxidative species are typically initiated by adding H2O2 to the reagents, buffers, or samples containing the DNA contaminants. Aqueous H2O2 solutions are available from chemical suppliers such as Sigma-Aldrich at a variety of concentrations, e.g., 3%, 10%, 30%. When metal ions are also present in a solution to which hydrogen peroxide is added, a number of oxidative species are created, as outlined above. The oxidative species, in turn degrade the DNA, as described above. In some embodiments, the initial concentration of H2O2 in the reagent, buffer, or sample is 1 μM or greater, e.g., 10 μM or greater, e.g., 100 μM or greater, e.g., 1 mM or greater, e.g., 10 mM or greater, e.g., 100 mM or greater. Because the H2O2 is consumed during the degradation process, the final concentration of H2O2 is typically smaller than the initial concentration of H2O2. The initial molar ratio of metal ions to peroxide ions in the solution may be between about 1:1 and about 1:50, e.g., about 1:1 to about 1:25, e.g., about 1:1 to about 1:10, e.g., about 1:5 to about 1:10.
In embodiments where it is feasible to adjust the pH (i.e., not buffers), the conditions of the DNA degradation may be adjusted by modifying the pH of the solution. This may be accomplished with the direct addition of acids (e.g., hydrochloric acid, sulfuric acid, or acetic acid) or bases (e.g., sodium hydroxide, potassium hydroxide). It may also be accomplished with the addition of acid- or base-generating species (e.g., chlorine gas, or sodium hypochlorite). In some embodiments, the pH of a degradation solution or a regent being decontaminated will be greater than or equal to pH=3, e.g., greater than or equal to pH=4, e.g., greater than or equal to pH=5, e.g., greater than or equal to pH=6, e.g., greater than or equal to pH=7, e.g., greater than or equal to pH=8, e.g., greater than or equal to pH=9, e.g., greater than or equal to pH=10, e.g., greater than or equal to pH=11, e.g., pH=12. In some embodiments, the pH of a degradation solution or a regent being decontaminated will be less than or equal to pH=12, e.g., less than or equal to pH=11, e.g., less than or equal to pH=10, e.g., less than or equal to pH=9, e.g., less than or equal to pH=8, e.g., less than or equal to pH=7, e.g., less than or equal to pH=6, e.g., less than or equal to pH=5, e.g., less than or equal to pH=4, e.g., pH=3. The solution may have a pH of from about 3 to about 12, e.g., from about 4 to about 11, e.g., from about 5 to about 10, e.g., from about 6 to about 9, e.g., from about 6 to about 8, e.g., about 7.
Prior to using the newly-prepared DNA-free reagents, buffers, or samples, it will often be necessary to remove excess oxidative species and/or metal ions. Typically, any excess H2O2 can be removed by heating the solution, thereby increasing the rate at which H2O2 dissociates into oxygen gas and water (see equation 2 above). With the removal of excess H2O2, there are few sources for additional oxidative species, and the degradation reactions will quickly terminate once the other oxidative species (e.g., superoxides, hydroxyl radicals) have reacted. In one embodiment, a reagent, buffer, or sample will be heated to at least about 35° C., e.g., at least about 40° C., e.g., at least about 45° C., e.g., at least about 50° C., e.g., at least about 55° C., e.g., at least about 60° C., e.g., at least about 65° C., e.g., at least about 70° C., e.g., at least about 75° C., e.g., at least about 80° C., e.g., at least about 85° C. The reagent, buffer, or sample will be heated for at least about 5 minutes, e.g., at least about 10 minutes, e.g., at least about 15 minutes, e.g., at least about 20 minutes, e.g., at least about 30 minutes, e.g., at least about 60 minutes. When samples containing proteins or RNA are being decontaminated, it is important to monitor the temperature of the solution during the decontamination so that the proteins or RNA are not damaged. For example, the solution may be kept at a temperature between 35 and 45° C. for a period of time to assure that all H2O2 is dissociated, but that the proteins or RNA remain, for the most part, intact.
In some heat-sensitive applications, it may be necessary to use enzymes that facilitate dissociation of oxidative species, such as superoxides, to deactivate reactive oxygen species. Enzymes such as superoxide dismutases (SODs) may be used to “turn off” the reactions once the degradation is complete. SOD is commercially available from Sigma-Aldrich. SOD may also sequester free metal ions, which are cofactors to the dissociate reactions, however this is not the dominant mechanism for reducing oxidative degradation. While SOD administration is an option for terminating oxidative degradation reactions, it is expensive and results in many of the same complications seen with the use of DNase (discussed above).
In addition to removing the oxidative species, e.g., H2O2, it may be beneficial to remove metal ions from the reagents, buffers, or samples after the degradation process is complete. Free metal ions can be removed using a number of known techniques, and some techniques will be better than others depending upon the intended use of the reagents, buffers, or samples. In one embodiment, the metal ions may be removed using an ion-exchange column, such as available from GE Healthcare Biosciences (Pittsburgh, Pa.). Using ion-exchange chromatography the reagents, buffers, or samples are put in contact with a stationary phase having ionic functional groups that bind ions of opposite charge, e.g., M2+. The reagents, buffers, or samples either pass through the stationary phase, as in a column, or the reagents, buffers, or samples are agitated with the stationary phase and then the stationary phase removed, decanted, etc.
In another embodiment, the free metal ions can be removed using chelating agents such as EDTA, citric acid, or phosphonates. Chelating agents are widely available from chemical suppliers such as Sigma-Aldrich. In some instances, the chelating agents do not remove the metal ions from the reagents, buffers, or samples, but rather deactivate them by forming complexes which remain in the solution. In other instances, the chelating agents cause the metal ions to precipitate from solution. The precipitate may be removed with filtering, for example.
The methods of the invention may also be used to decontaminate laboratory equipment, including labware, scientific instruments, and portions thereof. For example, an aqueous degradation solution comprising Fe2(SO4)3 and H2O2 may be prepared and the laboratory equipment allowed to soak (incubate) in the solution for some time, e.g., 1 hour or longer, 2 hours or longer, 4 hours or longer, 8 hours or longer, 12 hours or longer, or 24 hours or longer. After soaking, the laboratory equipment can be rinsed (soaked, incubated) with DNA-free water, and then allowed to dry in a DNA-free hood or baked in an oven.
In some instances, an aqueous solution comprising Fe2(SO4)3 and H2O2 can be used to decontaminate separation media, such as polymer beads or magnetic beads. In other embodiments, an aqueous solution comprising Fe2(SO4)3 and H2O2 can be used to decontaminate a support, i.e., the precursor to the separation medium. After preparation of a degradation solution, the separation media can be allowed to soak in the solution for some time, e.g., 1 hour or longer, 2 hours or longer, 4 hours or longer, 8 hours or longer, 12 hours or longer, or 24 hours or longer. In instances where the separation media is packed, e.g., in a column, it may be sufficient to add the degradation solution directly to the column and allow the separation media to soak in the presence of the degradation solution for some time, e.g., 1 hour or longer, 2 hours or longer, 4 hours or longer, 8 hours or longer, 12 hours or longer, or 24 hours or longer. The separation media can be rinsed with DNA-free water, and then allowed to dry in a DNA-free hood or baked in an oven. In some instances the separation media will be decontaminated prior to activation or binding of ligands e.g., antibodies. In other instances, the separation media will be decontaminated after the separation media has been activated or ligands bound thereto.
References and citations to other documents, such as patents, patent applications, patent publications, journals, books, papers, web contents, have been made throughout this disclosure. All such documents are hereby incorporated herein by reference in their entirety for all purposes.
The invention may be embodied in other specific forms without departing from the spirit or essential characteristics thereof. The foregoing embodiments are therefore to be considered in all respects illustrative rather than limiting on the invention described herein. Scope of the invention is thus indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.
The present application claims the benefit of and priority to U.S. provisional patent application Ser. No. 61/739,593 filed Dec. 19, 2012, the content of which is incorporated by reference herein in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3970518 | Giaever | Jul 1976 | A |
4018886 | Giaever | Apr 1977 | A |
4180563 | Fauve | Dec 1979 | A |
4230685 | Senyei et al. | Oct 1980 | A |
4267234 | Rembaum | May 1981 | A |
4434237 | Dinarello | Feb 1984 | A |
4452773 | Molday | Jun 1984 | A |
4551435 | Liberti et al. | Nov 1985 | A |
4554088 | Whitehead et al. | Nov 1985 | A |
4659678 | Forrest et al. | Apr 1987 | A |
4677055 | Dodin et al. | Jun 1987 | A |
4683195 | Mullis et al. | Jul 1987 | A |
4683202 | Mullis | Jul 1987 | A |
4695393 | Chagnon et al. | Sep 1987 | A |
4795698 | Owen et al. | Jan 1989 | A |
4901018 | Lew | Feb 1990 | A |
4925788 | Liberti | May 1990 | A |
4942124 | Church | Jul 1990 | A |
4988617 | Landegren et al. | Jan 1991 | A |
5047321 | Loken et al. | Sep 1991 | A |
5057413 | Terstappen et al. | Oct 1991 | A |
5089386 | Stackebrandt et al. | Feb 1992 | A |
5108933 | Liberti et al. | Apr 1992 | A |
5118603 | Popp | Jun 1992 | A |
5136095 | Tarnowski et al. | Aug 1992 | A |
5149625 | Church et al. | Sep 1992 | A |
5164297 | Josephson et al. | Nov 1992 | A |
5186827 | Liberti et al. | Feb 1993 | A |
5200084 | Liberti et al. | Apr 1993 | A |
5229724 | Zeiger | Jul 1993 | A |
5234816 | Terstappen | Aug 1993 | A |
5242794 | Whiteley et al. | Sep 1993 | A |
5254460 | Josephson et al. | Oct 1993 | A |
5338687 | Lee et al. | Aug 1994 | A |
5342790 | Levine et al. | Aug 1994 | A |
5460979 | Levine et al. | Oct 1995 | A |
5466574 | Liberti et al. | Nov 1995 | A |
5494810 | Barany et al. | Feb 1996 | A |
5512332 | Liberti et al. | Apr 1996 | A |
5541072 | Wang et al. | Jul 1996 | A |
5583024 | McElroy et al. | Dec 1996 | A |
5583033 | Terstappen et al. | Dec 1996 | A |
5597531 | Liberti et al. | Jan 1997 | A |
5604097 | Brenner | Feb 1997 | A |
5605805 | Verwer et al. | Feb 1997 | A |
5622831 | Liberti et al. | Apr 1997 | A |
5622853 | Terstappen et al. | Apr 1997 | A |
5636400 | Young | Jun 1997 | A |
5646001 | Terstappen et al. | Jul 1997 | A |
5654636 | Sweedler et al. | Aug 1997 | A |
5660990 | Rao et al. | Aug 1997 | A |
5674713 | McElroy et al. | Oct 1997 | A |
5677133 | Oberhardt | Oct 1997 | A |
5681478 | Lea et al. | Oct 1997 | A |
5684401 | Peck et al. | Nov 1997 | A |
5695934 | Brenner | Dec 1997 | A |
5695946 | Benjamin et al. | Dec 1997 | A |
5698271 | Liberti et al. | Dec 1997 | A |
5700673 | McElroy et al. | Dec 1997 | A |
5741714 | Liberti | Apr 1998 | A |
5768089 | Finnigan | Jun 1998 | A |
5770461 | Sakazume et al. | Jun 1998 | A |
5773307 | Colin et al. | Jun 1998 | A |
5776710 | Levine et al. | Jul 1998 | A |
5795470 | Wang et al. | Aug 1998 | A |
5821066 | Pyle et al. | Oct 1998 | A |
5834217 | Levine et al. | Nov 1998 | A |
5840580 | Terstappen et al. | Nov 1998 | A |
5846719 | Brenner et al. | Dec 1998 | A |
5858650 | Celebuski | Jan 1999 | A |
5863722 | Brenner | Jan 1999 | A |
5866099 | Owen et al. | Feb 1999 | A |
5869252 | Bouma et al. | Feb 1999 | A |
5876593 | Liberti et al. | Mar 1999 | A |
5925573 | Colin et al. | Jul 1999 | A |
5935825 | Nishimura et al. | Aug 1999 | A |
5948412 | Murphy | Sep 1999 | A |
5955583 | Beavo et al. | Sep 1999 | A |
5961879 | Trigiante | Oct 1999 | A |
5985153 | Dolan et al. | Nov 1999 | A |
5993665 | Terstappen et al. | Nov 1999 | A |
6013188 | Terstappen et al. | Jan 2000 | A |
6013532 | Liberti et al. | Jan 2000 | A |
6060882 | Doty | May 2000 | A |
6097188 | Sweedler et al. | Aug 2000 | A |
6100099 | Gordon et al. | Aug 2000 | A |
6120856 | Liberti et al. | Sep 2000 | A |
6136182 | Dolan et al. | Oct 2000 | A |
6138077 | Brenner | Oct 2000 | A |
6146838 | Williams et al. | Nov 2000 | A |
6150516 | Brenner et al. | Nov 2000 | A |
6172214 | Brenner | Jan 2001 | B1 |
6172218 | Brenner | Jan 2001 | B1 |
6194900 | Freeman et al. | Feb 2001 | B1 |
6228624 | Terstappen | May 2001 | B1 |
6235475 | Brenner et al. | May 2001 | B1 |
6236205 | Ludeke et al. | May 2001 | B1 |
6242915 | Hurd | Jun 2001 | B1 |
6265150 | Terstappen et al. | Jul 2001 | B1 |
6287791 | Terstappen et al. | Sep 2001 | B1 |
6307372 | Sugarman et al. | Oct 2001 | B1 |
6326787 | Cowgill | Dec 2001 | B1 |
6348318 | Valkirs | Feb 2002 | B1 |
6352828 | Brenner | Mar 2002 | B1 |
6361749 | Terstappen et al. | Mar 2002 | B1 |
6361944 | Mirkin et al. | Mar 2002 | B1 |
6365362 | Terstappen et al. | Apr 2002 | B1 |
6397094 | Ludeke et al. | May 2002 | B1 |
6404193 | Dourdeville | Jun 2002 | B1 |
6456072 | Webb et al. | Sep 2002 | B1 |
6469636 | Baird et al. | Oct 2002 | B1 |
6487437 | Viswanathan et al. | Nov 2002 | B1 |
6495357 | Fuglsang et al. | Dec 2002 | B1 |
6512941 | Weiss et al. | Jan 2003 | B1 |
6514415 | Hatch et al. | Feb 2003 | B2 |
6551843 | Rao et al. | Apr 2003 | B1 |
6555324 | Olweus et al. | Apr 2003 | B1 |
6582938 | Su et al. | Jun 2003 | B1 |
6587706 | Viswanathan | Jul 2003 | B1 |
6594517 | Nevo | Jul 2003 | B1 |
6620627 | Liberti et al. | Sep 2003 | B1 |
6623982 | Liberti et al. | Sep 2003 | B1 |
6623983 | Terstappen et al. | Sep 2003 | B1 |
6645731 | Terstappen et al. | Nov 2003 | B2 |
6660159 | Terstappen et al. | Dec 2003 | B1 |
6696838 | Raftery et al. | Feb 2004 | B2 |
6700379 | Peck et al. | Mar 2004 | B2 |
6788061 | Sweedler et al. | Sep 2004 | B1 |
6790366 | Terstappen et al. | Sep 2004 | B2 |
6818395 | Quake et al. | Nov 2004 | B1 |
6822454 | Peck et al. | Nov 2004 | B2 |
6845262 | Albert et al. | Jan 2005 | B2 |
6858384 | Terstappen et al. | Feb 2005 | B2 |
6867021 | Maes et al. | Mar 2005 | B2 |
6876200 | Anderson et al. | Apr 2005 | B2 |
6890426 | Terstappen et al. | May 2005 | B2 |
6898430 | Liberti et al. | May 2005 | B1 |
6914538 | Baird et al. | Jul 2005 | B2 |
6958609 | Raftery et al. | Oct 2005 | B2 |
7011794 | Kagan et al. | Mar 2006 | B2 |
7056657 | Terstappen et al. | Jun 2006 | B2 |
7078224 | Bitner et al. | Jul 2006 | B1 |
7096057 | Hockett et al. | Aug 2006 | B2 |
7141978 | Peck et al. | Nov 2006 | B2 |
7169560 | Lapidus et al. | Jan 2007 | B2 |
7200430 | Thomas et al. | Apr 2007 | B2 |
7202667 | Barbic | Apr 2007 | B2 |
RE39793 | Brenner | Aug 2007 | E |
7271592 | Gerald, II et al. | Sep 2007 | B1 |
7274191 | Park et al. | Sep 2007 | B2 |
7282180 | Tibbe et al. | Oct 2007 | B2 |
7282337 | Harris | Oct 2007 | B1 |
7282350 | Rao et al. | Oct 2007 | B2 |
7304478 | Tsuda et al. | Dec 2007 | B2 |
7332288 | Terstappen et al. | Feb 2008 | B2 |
7345479 | Park et al. | Mar 2008 | B2 |
7393665 | Brenner | Jul 2008 | B2 |
7403008 | Blank et al. | Jul 2008 | B2 |
7405567 | McDowell | Jul 2008 | B2 |
7523385 | Nguyen et al. | Apr 2009 | B2 |
7537897 | Brenner et al. | May 2009 | B2 |
7544473 | Brenner | Jun 2009 | B2 |
7564245 | Lee | Jul 2009 | B2 |
7666308 | Scholtens et al. | Feb 2010 | B2 |
7688777 | Liberti, Jr. et al. | Mar 2010 | B2 |
7764821 | Coumans et al. | Jul 2010 | B2 |
7815863 | Kagan et al. | Oct 2010 | B2 |
7828968 | Tibbe et al. | Nov 2010 | B2 |
7863012 | Rao et al. | Jan 2011 | B2 |
7901950 | Connelly et al. | Mar 2011 | B2 |
7943397 | Tibbe et al. | May 2011 | B2 |
8067938 | McDowell | Nov 2011 | B2 |
8102176 | Lee | Jan 2012 | B2 |
8110101 | Tibbe et al. | Feb 2012 | B2 |
8111669 | Liberti, Jr. et al. | Feb 2012 | B2 |
8128890 | Droog et al. | Mar 2012 | B2 |
8841104 | Dryga et al. | Sep 2014 | B2 |
8889368 | Barbreau et al. | Nov 2014 | B2 |
20010018192 | Terstappen et al. | Aug 2001 | A1 |
20020009759 | Terstappen et al. | Jan 2002 | A1 |
20020012669 | Presnell et al. | Jan 2002 | A1 |
20020098531 | Thacker | Jul 2002 | A1 |
20020130661 | Raftery et al. | Sep 2002 | A1 |
20020132228 | Terstappen et al. | Sep 2002 | A1 |
20020141913 | Terstappen et al. | Oct 2002 | A1 |
20020164629 | Quake et al. | Nov 2002 | A1 |
20020164659 | Rao et al. | Nov 2002 | A1 |
20020172987 | Terstappen et al. | Nov 2002 | A1 |
20030003441 | Colston et al. | Jan 2003 | A1 |
20030022231 | Wangh et al. | Jan 2003 | A1 |
20030054376 | Mullis et al. | Mar 2003 | A1 |
20030088181 | Gleich | May 2003 | A1 |
20030092029 | Josephson et al. | May 2003 | A1 |
20030129676 | Terstappen et al. | Jul 2003 | A1 |
20030138838 | Wang | Jul 2003 | A1 |
20030203507 | Liberti et al. | Oct 2003 | A1 |
20030206577 | Liberti et al. | Nov 2003 | A1 |
20030215818 | Lorenz | Nov 2003 | A1 |
20030222648 | Fan | Dec 2003 | A1 |
20040004043 | Terstappen et al. | Jan 2004 | A1 |
20040018611 | Ward et al. | Jan 2004 | A1 |
20040033916 | Kuzmin | Feb 2004 | A1 |
20040072269 | Rao et al. | Apr 2004 | A1 |
20040076990 | Picard et al. | Apr 2004 | A1 |
20040087032 | Chandler et al. | May 2004 | A1 |
20040101443 | Kagan et al. | May 2004 | A1 |
20040118757 | Terstappen et al. | Jun 2004 | A1 |
20040151629 | Pease et al. | Aug 2004 | A1 |
20050003464 | Tibbe et al. | Jan 2005 | A1 |
20050006990 | Williquette et al. | Jan 2005 | A1 |
20050026144 | Maes et al. | Feb 2005 | A1 |
20050037351 | Kanno | Feb 2005 | A1 |
20050043521 | Terstappen et al. | Feb 2005 | A1 |
20050069900 | Lentrichia | Mar 2005 | A1 |
20050079520 | Wu | Apr 2005 | A1 |
20050111414 | Liberti et al. | May 2005 | A1 |
20050128985 | Liberti et al. | Jun 2005 | A1 |
20050181353 | Rao et al. | Aug 2005 | A1 |
20050181463 | Rao et al. | Aug 2005 | A1 |
20050202491 | Nelson | Sep 2005 | A1 |
20050245814 | Anderson et al. | Nov 2005 | A1 |
20060024756 | Tibbe et al. | Feb 2006 | A1 |
20060105930 | McDonnell | May 2006 | A1 |
20060115380 | Kagan et al. | Jun 2006 | A1 |
20060129327 | Kim et al. | Jun 2006 | A1 |
20060147901 | Jan et al. | Jul 2006 | A1 |
20060194192 | Rao et al. | Aug 2006 | A1 |
20060233712 | Penades et al. | Oct 2006 | A1 |
20060257847 | Scholtens et al. | Nov 2006 | A1 |
20060257945 | Masters et al. | Nov 2006 | A1 |
20060281094 | Squirrell et al. | Dec 2006 | A1 |
20070037173 | Allard et al. | Feb 2007 | A1 |
20070037231 | Sauer-Budge et al. | Feb 2007 | A1 |
20070090836 | Xiang et al. | Apr 2007 | A1 |
20070114181 | Li et al. | May 2007 | A1 |
20070116602 | Lee | May 2007 | A1 |
20070117158 | Coumans et al. | May 2007 | A1 |
20070152669 | Park et al. | Jul 2007 | A1 |
20070152670 | Park et al. | Jul 2007 | A1 |
20070154960 | Connelly et al. | Jul 2007 | A1 |
20070166835 | Bobrow et al. | Jul 2007 | A1 |
20070183935 | Clemmens et al. | Aug 2007 | A1 |
20070231926 | Ikeda | Oct 2007 | A1 |
20070296413 | Park et al. | Dec 2007 | A1 |
20080026451 | Braman et al. | Jan 2008 | A1 |
20080042650 | McDowell | Feb 2008 | A1 |
20080081330 | Kahvejian | Apr 2008 | A1 |
20080099715 | Adams et al. | May 2008 | A1 |
20080113350 | Terstappen | May 2008 | A1 |
20080199851 | Egan et al. | Aug 2008 | A1 |
20080204011 | Shoji | Aug 2008 | A1 |
20080204022 | Sillerud et al. | Aug 2008 | A1 |
20080272788 | McDowell | Nov 2008 | A1 |
20080286838 | Yuan et al. | Nov 2008 | A1 |
20080315875 | Sillerud | Dec 2008 | A1 |
20090026082 | Rothberg et al. | Jan 2009 | A1 |
20090061456 | Allard et al. | Mar 2009 | A1 |
20090061476 | Tibbe et al. | Mar 2009 | A1 |
20090061477 | Tibbe et al. | Mar 2009 | A1 |
20090127589 | Rothberg et al. | May 2009 | A1 |
20090134869 | Lee | May 2009 | A1 |
20090136946 | Connelly et al. | May 2009 | A1 |
20090146658 | McDowell et al. | Jun 2009 | A1 |
20090148847 | Kokoris et al. | Jun 2009 | A1 |
20090156572 | Ikeura et al. | Jun 2009 | A1 |
20090173681 | Siddiqi | Jul 2009 | A1 |
20090191535 | Connelly et al. | Jul 2009 | A1 |
20090227044 | Dosev et al. | Sep 2009 | A1 |
20090246796 | Bernard et al. | Oct 2009 | A1 |
20090256572 | McDowell | Oct 2009 | A1 |
20090258365 | Terstappen et al. | Oct 2009 | A1 |
20090286264 | Scholtens et al. | Nov 2009 | A1 |
20100035252 | Rothberg et al. | Feb 2010 | A1 |
20100068723 | Jovanovich et al. | Mar 2010 | A1 |
20100072994 | Lee et al. | Mar 2010 | A1 |
20100086976 | Paranhos-Baccala | Apr 2010 | A1 |
20100129785 | Pris et al. | May 2010 | A1 |
20100137143 | Rothberg et al. | Jun 2010 | A1 |
20100144005 | Bin Kingombe et al. | Jun 2010 | A1 |
20100188073 | Rothberg et al. | Jul 2010 | A1 |
20100197507 | Rothberg et al. | Aug 2010 | A1 |
20100219824 | Sillerud et al. | Sep 2010 | A1 |
20100225315 | McDowell | Sep 2010 | A1 |
20100282617 | Rothberg et al. | Nov 2010 | A1 |
20100282788 | Liberti | Nov 2010 | A1 |
20100300559 | Schultz et al. | Dec 2010 | A1 |
20100300895 | Nobile et al. | Dec 2010 | A1 |
20100301398 | Rothberg et al. | Dec 2010 | A1 |
20100304982 | Hinz et al. | Dec 2010 | A1 |
20100326587 | Kagan et al. | Dec 2010 | A1 |
20110014686 | Tibbe et al. | Jan 2011 | A1 |
20110018538 | Lee | Jan 2011 | A1 |
20110044527 | Tibbe et al. | Feb 2011 | A1 |
20110046475 | Assif et al. | Feb 2011 | A1 |
20110052037 | Coumans et al. | Mar 2011 | A1 |
20110059444 | Stromberg et al. | Mar 2011 | A1 |
20110070586 | Slezak et al. | Mar 2011 | A1 |
20110086338 | Hwang et al. | Apr 2011 | A1 |
20110091987 | Weissleder et al. | Apr 2011 | A1 |
20110098623 | Zhang et al. | Apr 2011 | A1 |
20110104718 | Rao et al. | May 2011 | A1 |
20110183398 | Dasaratha et al. | Jul 2011 | A1 |
20110262893 | Dryga et al. | Oct 2011 | A1 |
20110262925 | Dryga et al. | Oct 2011 | A1 |
20110262926 | Esch et al. | Oct 2011 | A1 |
20110262927 | Dryga et al. | Oct 2011 | A1 |
20110262932 | Esch et al. | Oct 2011 | A1 |
20110262933 | Dryga et al. | Oct 2011 | A1 |
20110262989 | Clarizia et al. | Oct 2011 | A1 |
20110263833 | Dryga et al. | Oct 2011 | A1 |
20110300551 | Rao et al. | Dec 2011 | A1 |
20110301042 | Steinmann et al. | Dec 2011 | A1 |
20120045828 | Davis et al. | Feb 2012 | A1 |
20120094275 | Rao et al. | Apr 2012 | A1 |
20120095178 | Pressel | Apr 2012 | A1 |
20120100546 | Lowery, Jr. et al. | Apr 2012 | A1 |
20120112744 | McDowell et al. | May 2012 | A1 |
20120301926 | Chen | Nov 2012 | A1 |
20130109590 | Clarizia et al. | May 2013 | A1 |
20130196341 | Neely et al. | Aug 2013 | A1 |
20130203634 | Jovanovich et al. | Aug 2013 | A1 |
20130316355 | Dryga et al. | Nov 2013 | A1 |
20140100136 | Clarizia et al. | Apr 2014 | A1 |
20140170021 | Dryga | Jun 2014 | A1 |
20140170639 | Norvell | Jun 2014 | A1 |
20140170640 | Dykes | Jun 2014 | A1 |
20140170641 | Macemon | Jun 2014 | A1 |
20140170652 | Sitdikov et al. | Jun 2014 | A1 |
20140170667 | Dykes et al. | Jun 2014 | A1 |
20140170669 | Vandervest | Jun 2014 | A1 |
20140170727 | Dryga et al. | Jun 2014 | A1 |
20140171340 | Dykes et al. | Jun 2014 | A1 |
20150212079 | Dryga et al. | Jul 2015 | A1 |
Number | Date | Country |
---|---|---|
2 342 047 | Sep 2001 | CA |
1 304 581 | Apr 2003 | EP |
8906699 | Jul 1989 | WO |
9008841 | Aug 1990 | WO |
9102811 | Mar 1991 | WO |
9208805 | May 1992 | WO |
9215883 | Sep 1992 | WO |
9531481 | Nov 1995 | WO |
9820148 | May 1998 | WO |
9953320 | Oct 1999 | WO |
0173460 | Oct 2001 | WO |
02098364 | Dec 2002 | WO |
2005026762 | Mar 2005 | WO |
2005106480 | Nov 2005 | WO |
2007018601 | Feb 2007 | WO |
2007123345 | Nov 2007 | WO |
2007135099 | Nov 2007 | WO |
2007123342 | Nov 2007 | WO |
2008119054 | Oct 2008 | WO |
2008139419 | Nov 2008 | WO |
2009048673 | Apr 2009 | WO |
2009055587 | Apr 2009 | WO |
2009122216 | Oct 2009 | WO |
2011019874 | Feb 2011 | WO |
2011133630 | Oct 2011 | WO |
2011133632 | Oct 2011 | WO |
2011133759 | Oct 2011 | WO |
2011133760 | Oct 2011 | WO |
Entry |
---|
Mulder, et al., Characterization of two human monoclonal antibodies reactive with HLA-B12 and HLA-B60, respectively, raised by in vitro secondary immunization of peripheral blood lymphocytes, Hum. Immunol., 36(3):186-192 (1993). |
Nyquist, Thermal Agitation of Electrical Charge in Conductors, Phys. Rev., 32:110-113 (1928). |
Margin, et al., High resolution microcoil 1H-NMR for mass-limited, nanoliter-volume samples, Science, 270:1967 (1995). |
Olson, et al., High-resolution microcoil NMR for analysis of mass-limited, nanoliter samples, Anal. Chem., 70:645-650 (1998). |
Pappas, et al., Cellular Separations: A Review of New Challenges in Analytical Chemistry, Analytica Chimica Acta, 601(1):26-35 (2007). |
Peck, et al., Design and Analysis of Microcoils for NMR Microscopy, J. Magn. Reson. B 108:114-124 (1995). |
Peck, et al., RF Microcoils patterned using microlithographic techniques for use as microsensors in NMR, Proc. 15th Ann. Int. Conf. of the IEEE, Oct. 28-31, pp. 174-175 (1993). |
Perez, et al., Viral-induced self-assembly of magnetic nanoparticle allows detection of viral particles in biological media, J. Am. Chem. Soc., 125:10192-10193 (2003). |
Qiu, et al., Immunomagnetic separation and rapid detection of bacteria using bioluminescence and microfluidics, Talanta, 79:787-795 (2009). |
Rogers, et al., Using microcontact printing to fabricate microcoils on capillaries for high resolution proton nuclear magnetic resonance on nanoliter volumes, Appl. Phys. Lett., 70:2464-2466 (1997). |
Seeber, et al., Design and Testing of high sensitivity Microreceiver Coil Apparatus for Nuclear Magnetic Resonance and Imaging, Rev. Sci. Inst., 72:2171-2179 (2001). |
Seeber, et al., Triaxial Magnetic Field Gradient System for Microcoil Magnetic Resonance Imaging, Rev. Sci. Inst., 71:4263-4272 (2000). |
Sillerud, et al., 1H NMR Detection of Superparamagnetic Nanoparticles at 1 T using a Microcoil and Novel Tuning Circuit, J. Magn. Reson. 181:181-190 (2006). |
Skjerve, et al., Detection of Listeria monocytogenes in foods by immunomagnetic separation, Appl. Env. Microbiol., 56:3478 (1990). |
Sorli, et al., Micro-spectrometer for NMR: analysis of small quantities in vitro, Meas. Sci. Technol., 15:877-880 (2004). |
Stanley, Essentials in Immunology and Serology, Delmar, pp. 153-153 (2002). |
Stauber, et al. Rapid generation of monoclonal antibody-secreting hybridomas against African horse sickness virus by in vitro immunization and the fusion/cloning technique, J. Immunol. Methods, 161(2):157-168 (1993). |
Stocker, et al. Nanoliter volume, high-resolution NMR Microspectroscopy using a 60 um planer microcoil, IEEE Trans. Biomed. Eng., 44:1122-1127 (1997). |
Subramanian, et al., RF Microcoil Design for Practical NMR of Mass-Limited Samples, J. Magn. Reson., 133:227-231 (1998). |
Taktak, et al., Multiparameter Magnetic Relaxation Switch Assays, Analytical Chemistry, 79(23):8863-8869 (2007). |
Torensama, et al., Monoclonal Antibodies Specific for the Phase-Variant O-Acetylated Ki Capsule of Escerichia coli, J. Clin. Microbiol., 29(7):1356-1358 (1991). |
Trumbull, et al., Integrating microfabricated fluidic systems and NMR spectroscopy, IEEE Trans. Biomed. Eng., 47(1):3-7 (2000). |
Van Bentum, et al., Towards Nuclear Magnetic Resonance (MU)-Spectroscopy and (MU)-Imaging, Analyst, Royal Society of Chemistry, London, 129(9):793-803 (2004). |
Venkateswaran, et al., Production of Anti-Fibroblast Growth Factor Receptor Monoclonal Antibodies by In Vitro Immunization, Hybridoma, 11(6):729-739 (1992). |
Vermunt, et al., Isolation of salmonelas by immunomagnetic separation, J. Appl. Bact., 72:112-118 (1992). |
Wang and Irudayaraj, Multifunctional Magnetic-Optical Nanoparticle Probes for Simultaneous Detection, Separation, and Thermal Ablation of Multiple Pathogens, Small, 6(2):283-289 (2010). |
Webb and Grant, Signal-to-Noise and Magnetic Susceptibility Trade-offs in Solenoidal Microcoils for NMR, J. Magn. Reson. B, 113:83-87 (1996). |
Wensink, et al., High Signal to Noise Ratio in Low-field NMR on a Chip: Simulations and Experimental Results, 17th IEEE MEMS, 407-410 (2004). |
Williams and Wang, Microfabrication of an electromagnetic power micro-relay using SU-8 based UV-LIGA technology, Microsystem Technologies, 10(10):699-705 (2004). |
Wu, et al., 1H-NMR Spectroscopy on the Nanoliter Scale for Static and On-Line Measurements, Anal. Chem., 66:3849 (1994). |
Zhao, et al. A rapid bioassay for single bacterial cell quantitation using bioconjugated nanoparticles, PNAS, 101(42):15027-15032 (2004). |
Zordan, et al., Detection of Pathogenic E. coli O157:H7 by a Hybrid Microfluidic SPR and Molecular Imaging Cytometry Device, Cytometry A, 75A:155-162 (2009). |
Extended European Search Report, dated Oct. 15, 2013 for EP application No. 11772606.7. |
International Search Report issued in PCT/US2013/076649, dated Feb. 27, 2014. |
Chungang Wang et al. “Multifunctional Magnetic-OPtical Nanoparticle Probes for Simultaneous Detection, Separation, and Thermal Ablation of Multiple Pathogens”, Small, vol. 6, No. 2 Jan. 18, 2010, pp. 283-289. |
Madonna A J, et al. “Detection of Bacteria from Biological Mixtures Using Immunomagnetic Separation Combined with Matrix-Assisted Laser Desorption/Ionization Time-of-flight Mass Spectrometry”, Rapid Communications in Mass Spectrometry, John Wiley & Sons, GB, vol. 15, No. 13, Jan. 1, 2001, pp. 1068-1074. |
Extended European Search Report issued in EP 11864030.9, dated Aug. 20, 2014. |
Fung, M-C., et al. PCR amplification of mRNA directly from a crude cell lysate prepared by thermophilic protease digestion, Nucleic Acids Research, vol. 19 (15), p. 4300, 1991. |
Dynabeads® for Immunoassay IVD, retrieved from http://www.in vitrogen.com/site/i3s/en/home/Products-and-Services/Applications/DiagnosticsClinical-Research/Bead-based-IVD-Assays/Bead-based-Immunoassav-iVD.html on May 29, 2013, four pages). |
Burtis et al. (Burtis, C.A. (Ed.), Tietz Textbook of Clinical Chemistry, 3rd Edition (1999), W.B. Saunders Company, Philadelphia, PA, pp. 1793-1794). |
Cooper et al., 2011, A micromagnetic flux concentrator device for isolation and visualization of pathogens. 15th International Conference on Miniaturized Systems for Chemistry and Life Sciences. Oct. 2-6, 2011, Seattle, Washington, USA. |
Griffiths et al., 1994, Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J. 13(14):3245-3260. |
Moreira et al., 2008, Detection of Salmonella Typhimurium in Raw Meats using In-House Prepared Monoclonal Antibody Coated Magnetic Beads and PCR Assay of the fimA Gene. Journal of Immunoassay & Immunochemistry 29:58-69. |
Yeung et al., 2002, Quantitative Screening of Yeast Surface-Displayed Polypeptide Libraries by Magnetic Bead Capture. Biotechnol. 18:212-220. |
International Search Report for PCT/US2013/076649 with an International filing date of Dec. 19, 2013, 2 pages. |
ISR and Written Opinion in PCT/US2008/058518, dated Sep. 29, 2009, 15 pages. |
Gu et al., 2003, Using Biofunctional Magentic Nanoparticles to Capture Vancomycin-Resistant Enterococci and Other Gram-Positive Bacteria at Ultralow Concentration, J. Am. Chem. Soc., 125:15702-15703. |
Gu et al., 2006, Biofunctional magnetic nanoparticles for protein separation and pathogen detection, Chem. Commun.:941-949. |
Heijnen et al., 2009, Method for rapid detection of viable Escherichia coli in water using real-time NASBA, Water Research, 43:3124-3132. |
Li et al., 2010, Chemiluminescent Detect of E. coli O157:H7 Using Immunological Method Based on Magnetic Nanoparticles, J. of Nanoscience and Nanotechnology 10:696-701. |
Abagram, Principles of Nuclear Magnetism, Carendon Press, Oxford, 1961, pp. 71-83. |
Armenean, et al., NMR Radiofrequency Microcoil Design: Electromagnetic Simulation Usefulness, Compes Rendus Biologies, 325(4):457-463 (2002). |
Armenean, et al., Solenoidal and Planar Microcoils for NMR Spectroscopy, Proc. of the 25th Annual Int. Conf. of the IEEE Eng. in Med. and Bio. Soc., Cancun, Mexico, Sep. 17, 2003, pp. 3045-3048. |
Behnia and Webb, Limited-Sample NMR Using Solenoidal Microcoils, Perfluorocarbon Plugs, and Capillary Spinning, Anal. Chem., 70:5326-5331 (1998). |
Byrne, et al., Antibody-Based Sensors: Principles, Problems and Potential for Detection of Pathogens and Associated Toxins, Sensors, 9:4407-4445 (2009). |
Chapman, et al., Use of commercial enzyme immunoassays and immunomagnetic separation systems for detecting Escherichia coli O157 in bovine fecal samples, Applied and Environmental Microbiology, 63(7):2549-2553 (1997). |
Ciobanu and Pennington, 3D Micron-scale MRI of Single Biological Cells, Solid State Nucl. Magn. Reson., 25:138-141 (2004). |
Cross, et al., Choice of Bacteria in Animal Models of Sepsis, Infec. Immun. 61(7):2741-2747 (1983). |
Djukovic, et al., Signal Enhancement in HPLC/Microcoil NMR Using Automated Column Trapping, Anal. Chem., 78:7154-7160 (2006). |
Drancourt, et al., Diagnosis of Mediterranean Spotted Fever by Indirect Immunofluorescence of Rickettsia conorii in circulating Endothelial Cells Isolated with Monoclonal Antibody-Coated Immunomagnetic Beads, J. Infectious Diseases, 166(3):660-663, 1992. |
Fan, et al., Self-assembly of ordered, robust, three-dimensional gold nanocrystal/silica arrays, Science, 304:567 (2004). |
Fu, et al., Rapid Detection of Escherichia coli O157:H7 by Immunogmagnetic Separation and Real-time PCR, Int. J. Food Microbiology, 99(1):47-57, (2005). |
Fukushima et al., Experimental Pulse NMR: A Nuts and Bolts Approach, Addison-Wesley, Reading, Mass., 1981. |
Goding, J.W., Conjugation of antibodies with fluorochromes: modifications to the standard methods, J. Immunol. Meth., 13:215 (1976). |
Goloshevsky, et al., Development of Low Field Nuclear Magnetic Resonance Microcoils, Rev. Sci. Inst.., 76:024101-1 to 024101-6 (2005). |
Goloshevsky, et al., Integration of Biaxial Planar Gradient Coils and an RF Microcoil for NMR Flow Imaging, Meas. Sci. Technol., 16:505-512 (2005). |
Grant, et al., Analysis of Multilayer Radio Frequency Microcoils for Nuclear Magnetic Resonance Spectroscopy, IEEE Trans. Magn., 37:2989-2998 (2001). |
Grant, et al., NMR Spectroscopy of Single Neurons, Magn. Reson. Med., 44:19-22 (2000). |
Halbach, Design of Permanent Multipole Magnets with Oriented Rare Earth Cobalt Material, Nuclear Instrum Methods, 169:1-10 (1980). |
Harada, et al., Monoclonal antibody G6K12 specific for membrane-associated differentiation marker of human stratified squamous epithelia and squamous cell carcinoma, J. Oral. Pathol. Med., 22(4):1145-152 (1993). |
Harlow, et al., 1988, ‘Antibodies’, Cold Spring Harbor Laboratory, pp. 93-117. |
Hijmans, et al., An immunofluorescence procedure for the detection of intracellular immunoglobulins, Clin. Exp. Immunol., 4:457 (1969). |
Hirsch, et al., Easily reversible desthiobiotin binding to streptavidin, avidin, and other biotin-binding proteins: uses for protein labeling, detection, and isolation, Anal. Biochem., 208(2):343-57 (2002). |
Hoult and Richards, The Signal-to-Noise Ratio of the Nuclear Magnetic Resonance Experiment, J. Magn. Reson., 24:71-85 (1976). |
Hunter, et al., Immunoassays for Clinical Chemistry, pp. 147-162, Churchill Livingston, Edinborough (1983). |
Inai, et al., Immunohistochemical detection of an enamel protein-related epitope in rat bone at an early stage of osteogenesis, Histochemistry, 99(5):335-362 (1993). |
Engvall, Enzyme immunoassay ELISA and EMIT, Meth. in Enzymol., 70:419-439 (1980). |
ISR and Written Opinion in PCT/US2008/058518, dated Jul. 7, 2008, 21 pages. |
ISR and Written Opinion in PCT/US2008/062473, dated Oct. 29, 2008, 20 pages. |
ISR and Written Opinion in PCT/US2008/080983, dated Mar. 3, 2009, 14 pages. |
ISR and Written Opinion in PCT/US2009/067577, dated Feb. 5, 2010, 13 pages. |
International Search Report in PCT/US2011/33184, dated Jul. 25, 2011, 2 pages. |
International Search Report in PCT/US2011/33186, dated Jun. 22, 2011, 1 page. |
ISR and Written Opinion in PCT/US2011/48447, dated Dec. 22, 2011, 7 pages. |
ISR and Written Opinion in PCT/US2011/48452, dated Dec. 22, 2011, 7 pages. |
International Search Report in PCT/US2011/33411, dated Jun. 22, 2011, 1 page. |
International Search Report in PCT/US2011/33410, dated Jul. 19, 2011, 2 pages. |
Johne, et al., Staphylococcus aureus exopolysaccharide in vivo demonstrated by immunomagnetic separation and electron microscopy, J. Clin. Microbiol. 27:1631-1635 (1989). |
Johnson, Thermal Agitation of Electricity in Conductors, Phys. Rev., 32:97-109 (1928). |
Kaittanis, et al., One-step nanoparticle mediated bacterial detection with magentic relaxation, Nano Lett., 7(2):381-383 (2007). |
Lee, et al., Chip-NRM Biosensor for detection and molecular analysis of cells, Nature Medicine, 14(8):869-874 (2008). |
Lund, et al. Immunomagnetic separation and DNA hybridization for detection of enterotoxigenic Escherichia coli in a piglet model, J. Clin. Microbiol., 29:2259-2262 (1991). |
Magin, et aL, Miniature Magnetic Resonance Machines, IEEE Spectrum 34(10):51-61 (1997). |
Malba, et al., Laser-lathe Lithography—A Novel Method for Manufacturing Nuclear Magnetic Resonance Microcoils, Biomed. Microdev., 5:21-27 (2003). |
Massin, et al., Planar Microcoil-based magnetic resonance imaging of cells, Transducers '03, The 12th Int. Conf. on Solid State Sensors, Actuators, and Microsystems, Boston, Jun. 8-12, pp. 967-970 (2003). |
Massin, et al., Planar Microcoil-based Microfluidic NMR Probes, J. Magn. Reson., 164:242-255 (2003). |
McDowell, et al., Low-Field Micro-Coil Probe Development for Portable NMR, 8th ICMRM, The Heidelberg Conference, Mibu, Japan, Aug. 22-26, 2005, Conference Program Abstract, 1 page. |
McDowell, et al., Operating Nanoliter Scale NMR Microcoils in a Itesla Field, J. Mag. Reson., 188(1):74-82 (2007). |
Minard, et al., Solenoidal Microcoil Design, Part I: Optimizing RF Homogeneity and coil dimensions, Concepts in Magn Reson., 13(2):128-142 (2001). |
Moresi and Magin, Miniature Permanent Magnet for Table-top NMR, Concept. Magn. Res., 19B:35-43 (2003). |
Sista et al., 2008, Heterogeneous Immunoassays Using Magnetic beads on a Digital Microfluidic Platform, Lab Chip 8(2):2188-2196. |
Butter et al., 2002, Synthesis and properties of iron ferrofluids, J. Magn. Magn. Mater. 252:1-3. |
Lu et al., 2007, Magnetic Nanoparticles: Synthesis, Protection, Functionalization, and Application, Angew. Chem. Int. Ed. 46:1222-1244. |
Matar et al., 1990, Magnetic particles derived from iron nitride, IEEE Transactions on magnetics 26(1):60-62. |
Cold Spring Harbor Protocols, Recipe for Dulbecco's phosphate-buffered saline (Dulbecco's PBS, 2009, retrieved from http://cshprotocols.cshlp.Org/content/2009/3/pdb.rec11725. full?text—only=true on Mar. 9, 2015, one page. |
Cheng et al, 2012, Concentration and detection of bacteria in virtual environmental samples based on non-immunomagnetic separation and quantum dots by using a laboratory-made system, Proc. of SPIE:82310Y-1-82310Y-18. |
Ohno et al, 2011, Effects of Blood Group Antigen-Binding Adhesin Expression during Helicobacter pylori Infection of Mongolian Gerbils, The Journal of Infectious Diseases 203:726-735. |
Barany F. (1991) PNAS 88:189-193. |
Narang et al., Methods Enzymol., 68:90 (1979). |
Brown et al., Methods Enzymol., 68:109 (1979). |
DNA Replication 2nd edition, Komberg and Baker, W.H. Freeman, New York, NY (1991). |
Barany et al., Gene, 108:1 (1991). |
Hinnisdales et al., Biotechniques Res., 19:4193 (1996). |
Myers and Gelfand, Biochemistry 30:7661 (1991). |
Stenish and McGowan, Biochim Biophys Acta, 475:32 (1977). |
Levin, Cell 88:5-8 (1997). |
Kleinstruer, “Microfluidics and Nanofluidics: Theory and Selected Applications,” John Wiley & Sons, 2013. |
Maniatis et al., Molecular Cloning: A Laboratory Manual, 1982, Cold Spring Harbor, NY, pp. 280-281. |
Sambrook and Russell, Molecular Cloning: A Laboratory Manual 3Ed, Cold Spring Harbor Laboratory Press, 2001. |
Barany, F., Genome research, 1:5-16 (1991). |
Margulies et al., Nature, 437: 376-380 (2005). |
Olsvik—et—al—Magnetic—Seperation—Techniques—in—Diagnostic—Microbiology—Clinical—Microbiol—Rev—1994—7—43—54. |
Chandler et al., Automated immunomagnetic separation and microarray detection of E. Coli O157:H7 from poultry carcass rinse, Int. J. Food Micro., 70 (2001) 143-154. |
Bruno et al., “Development of an Immunomagnetic Assay System for Rapid Detection of Bacteria and Leukocytes in Body Fluids,” J Mol Recog, 9 (1996) 474-479. |
Andreassen, Jack, “One micron magnetic beads optimised for automated immunoassays” as Published in CLI Apr. 2005, retrieved from http://www.cli-online.com/uploads/tx—ttproducts/datasheet/one-micron-magnetic-beads-optimised-for-automatedimmunoassays.pdf on Dec. 28, 2015, four pages. |
Safarik et al., “The application of magnetic separations in applied Microbiology” Journal of Applied Bacteriology 1995, 78, 575-585. |
Dam et al. “Garlic (Allium sativum) Lectins Bind to High Mannose Oligosaccharide Chains”, Journal of Biological Chemistry vol. 273, No. 10, Issue of Mar. 6, pp. 5528-5535, 1998. |
Fenwick et al., 1986, Mechanisms Involved in Protection Provided by Immunization against Core Lipopolysaccarides of Escherichia coli J5 from Lethal Haemophilus pleuropneumoniae Infections in Swine, Infection and Immunity 53(2):298-304. |
Yu et al. “Development of a Magnetic Microplate Chemifluorimmunoassay for Rapid Detection of Bacteria and Toxin in Blood”, Analytical Biochemistry 261 (1998), pp. 1-7. |
The United States Naval Research Laboratory (NRL), “The FABS Device: Magnetic Particles”, retrieved from http://www.nrl.navy.mil/chemistry/6170/6177/beads.php on Jan. 8, 2013, two pages. |
Life Technologies, “Dynabeads® for Immunoassay IVD”, retrieved from http://www.invitrogen.com/site/us/en/home/Productsand-Services/Applications/Diagnostics-Clinical-Research/Bead-based-IVD-Assays/Bead-based-Immunoassay-IVD.html on May 29, 2013, four pages. |
Campuzano, et al., Bacterial Isolation by Lectin Modified Microengines, Nano Lett. Jan. 11, 2012; 12(1): 396-401. |
Agrawal et al., 1990, Tetrahedron Letters 31:1543-46. |
Harkins and Harrigan, “Labeling of Bacterial Pathogens for Flow Cytometric Detection and Enumeration” Curr Prot Cytom (2004) 11.17.1-11.17.20. |
Takagi et al., Appl. Environ. Microbiol. 63:4504 (1997). |
Cariello et al., Nucl Acids Res, 19:4193 (1991). |
Lecomte et al. Nucl Acids Res. 11:7505 (1983). |
Cann et al., Proc. Natl. Acad. Sci. 95:14250 (1998). |
Braslavsky et al., PNAS, 100:3690-3694 (2003). |
Moudrianakis et al., Proc. Natl. Acad. Sci. 53:564-71 (1965). |
Vandeventer, J. Clin. Microbiol. Jul. 2011, 49(7):2533-39. |
Carroll, N. M., E. E. Jaeger, et al. (2000). “Detection of and discrimination between grampositive and gram-negative bacteria in intraocular samples by using nested PCR.” J Clin 15 Microbiol 38(5): 1753-1757. |
Klaschik, S., L. E. Lehmann, et al. (2002). “Real-time PCR for detection and differentiation of gram-positive and gram-negative bacteria.” J Clin Microbiol 40(11): 4304-4307. |
Chien et al., J. Bacteriol, 127:1550 (1976). |
Nordstrom et al., J. Biol. Chem. 256:3112 (1981). |
Elnifro, Elfath M., et al. “Multiplex PCR: optimization and application in diagnostic virology.” Clinical Microbiology Reviews 13.4 (2000): 559-570. |
Soni et al., Clin Chem 53:1996-2001 (2007). |
Diaz et al., Braz J. Med. Res., 31:1239 (1998). |
Verma, Biochim Biophys Acta. 473:1-38 (1977). |
Harris et al., Science 320:106-109 (2008). |
Dover, Jason E., et al. “Recent advances in peptide probe-based biosensors for detection of infectious agents.” Journal of microbiological methods 78.1 (2009): 10-19. |
Number | Date | Country | |
---|---|---|---|
20140170021 A1 | Jun 2014 | US |
Number | Date | Country | |
---|---|---|---|
61739593 | Dec 2012 | US |